Picture of U.S. Food and Drug Administration red banner

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

May 9 - May 31, 2002

FDA Official and Title Date and Site Other FDA Participants Non-FDA Participants Subject
Daniel E. Troy, Chief Counsel 5/15 Rockville, MD Elizabeth Dickinson (by phone), Fred Ansell, Kim Dettelbach Danielle Stinemetz, Ralph A. Mittelberger, James N. Czaban, Heller-Ehrman,; Richard S. Egosi, Debbie Jaskot, TEVA PharmaceuticalsDiscussion re: Tramadol ANDA approval issues
Daniel E. Troy, Chief Counsel 5/16 FDA/Washington, DC By Phone: Fred Ansell, Kim Detelbach, Elizabeth Dickinson, OCC; Virginia Beakes, CDER Steven Giuli, Kathleen Jaeger, GPhA; Judith Milford, TEVA Orange Book Patent Listings
Daniel E. Troy, Chief Counsel 5/22 Rockville, MD Annette Marthaler Michael R. Bruno, II, Michael R. Bruno, Bruno Independent Living Aids; Fred Rikkers, Dennis J. Purtell; Whyte, Hirschboeck, Dudek Enforcement Issue
Daniel E. Troy, Chief Counsel 5/22 Rockville, MD Annette Marthaler, Catherine Cook Ludwig Simmett, Minitube of America; Fred Rikkers, Dennis J. Purtell, Whyte, Hirschboeck, Dudek Technologic Developments in ART
Daniel E. Troy, Chief Counsel 5/28 Rockville, MD Kim Dettelbach, Fred Ansell, OCC; Jane Axelrad, Gary Buehler, CDER Dr. Marc Kamin, Helen Torelli, J&J; Alan Bennett, Terry Coleman, Bennett, Turner & Coleman Ultram
Daniel E. Troy, Chief Counsel 5/30 FDA/Washington, DC Karen Schifter, Mike Landa, Fred Ansell, Kim Dettelbach, Liz Dickinson (by phone) Francis D. Cerrito, Pennie & Edmonds; Peter Mathers, Richard Morey, Kleinfeld, Kaplan & Becker Omeprazole
Daniel E. Troy, Chief Counsel 5/31 Philadelphia, PA   Federalist Society Members and Drug Industry Gave a presentation on FDA issues
Kathryn C. Zoon, Ph.D., Director, Center for Biologics Evaluation and Research 5/10 Bethesda, MD None Wyeth Reps Discussion of potential shortages due to Consent Decree
Kathryn C. Zoon, Ph.D., Director, Center for Biologics Evaluation and Research 5/23 Washington, DC None BIO Reps Discuss creation of new office: Cellular and Gene Therapy
Kathryn C. Zoon, Ph.D., Director, Center for Biologics Evaluation and Research 5/23 Bethesda, MD None Wyeth Reps Smallpox
Kathryn C. Zoon, Ph.D., Director, Center for Biologics Evaluation and Research 5/28 Bethesda, MD other FDA employees CDC Discuss Aventis Pasteur Smallpox Vaccine

Public Calendar Archives | FDA Home Page | Search | A-Z Index | Site Map | Contact FDA

FDA/Website Management Staff
Web page created by tg 2002-JUN-06.